¼¼°èÀÇ ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM) ¼Ö·ç¼Ç ½ÃÀå Àü¸Á(-2027³â)
Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast
»óǰÄÚµå : 1285016
¸®¼­Ä¡»ç : Frost & Sullivan
¹ßÇàÀÏ : 2023³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 77 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,894,000
Web Access (Regional License) help
Frost & SullivanÀÇ À¥»çÀÌÆ® ·Î±×ÀÎ ÆÐ½º¿öµå°¡ ¹ßÇàµÇ¸ç, PDF¸¦ ´Ù¿î·Îµå ¹Þ´Â ÇüÅ·ΠÁ¦°øµÉ ¿¹Á¤ÀÔ´Ï´Ù. PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ ¸ðµç ºÐµéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù


Çѱ۸ñÂ÷

º» º¸°í¼­´Â ¼¼°è ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM, Continuous Glucose Monitoring) ¼Ö·ç¼Ç ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ, ±â¼ú µ¿Çâ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Àü·«Àû Çʼö¿ä°Ç

¼ºÀå ±âȸ ºÐ¼®

Áö¿ª ¹× ±¹°¡º° ±âȸ ºÐ¼®

CGM TAM

»õ·Î¿î ºñÁî´Ï½º ¸ðµ¨°ú ±â¼ú

¼ºÀå ±âȸ ºÐ¼® - ȨÄɾî ȯ°æ

¼ºÀå ±âȸ ºÐ¼® - º´¿ø, ±âŸ Äɾî ȯ°æ

¼ºÀå ±âȸ

´ÙÀ½ ´Ü°è

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Opportunities in Type 2 Diabetic and Non diabetic Patients Treatment Boost Future Growth Potential

The rising prevalence of diabetes entails a greater need for treatment and monitoring. In this context, multiple growth opportunities arise in the continuous glucose monitoring (CGM) solutions market. CGM devices have been extensively used for Type 1 diabetes patients. With further technological development and clinical studies, CGM's applications expand toward Type 2 diabetes, prediabetes, weight management, nutrition tracking, and metabolic health tracking.

Most Type 1 diabetes patients-the main users of CGM-do not use these solutions due to their high costs and low reimbursements, especially in low- and middle-income countries. The adoption of these devices is very low in Asia-Pacific, Latin America, and the Middle East and Africa due to low accessibility, awareness, and affordability. A vast patient pool of diabetic and prediabetic patients needing treatment in these regions creates attractive opportunities for CGM vendors.

Vendors in the CMG solutions industry are partnering with various players across the diabetes treatment ecosystem to increase CGM adoption, data integration, and device combability. Examples of these partnerships are common between CGM vendors and insulin pen, insulin pump, and diabetes management platform providers. Technological advancements and strategic partnerships create new opportunities for CGM vendors.

Research Highlights:

Table of Contents

Strategic Imperatives

Growth Opportunity Analysis

Regional and Country Opportunities Analysis

Total Addressable Market for CGM

New Business Models and Technologies

Growth Opportunity Analysis-Homecare Settings

Growth Opportunity Analysis-Hospitals and Other Care Settings

Growth Opportunity Universe

Next Steps

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â